Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
RSV stands for respiratory syncytial virus, a common contagious virus that infects the lungs and airways and spreads through coughs, sneezes, and contaminated surfaces. Most people experience mild, cold-like symptoms such as runny nose, cough, sneezing, and fever, but RSV can become serious in infants, older adults, and those with weakened immune systems or chronic heart and lung conditions. In severe cases it leads to bronchiolitis or pneumonia, and symptoms often peak around days three to five of illness. There are several important details about transmission, timing, risk factors, and warning signs that require urgent care, so see below to understand more.
Because RSV can look identical to a cold, the flu, or COVID-19 in its early stages, guessing at the cause can delay care that matters, especially for young children and older adults; a few minutes spent on a free, instant, online symptom check can help you compare your symptoms against likely conditions, clarify whether you should monitor at home or contact a clinician, and give you clear language to describe what you are experiencing at your next appointment.
Last reviewed for medical accuracy: 09/23/2026
Respiratory Syncytial Virus (RSV) is one of the most common causes of respiratory infections, especially in young children and older adults. Understanding what RSV stands for and how it behaves can help you recognize symptoms early, take preventive measures, and seek proper care when needed.
RSV stands for Respiratory Syncytial Virus.
RSV is an RNA virus in the Pneumoviridae family. First identified in the 1950s, it has since been recognized as a leading cause of:
Key characteristics:
While RSV can infect people of all ages, certain groups face higher risk of severe illness:
Symptoms typically appear 2–8 days after exposure and can range from mild to severe. Common signs include:
In severe cases, especially in high-risk groups, RSV can lead to:
RSV transmits easily from person to person:
The virus can live for hours on hard surfaces and for shorter periods on skin.
You can reduce the risk of RSV infection by following simple measures:
For certain high-risk infants, doctors may recommend a monthly injection of monoclonal antibodies during RSV season to help prevent severe disease.
Most RSV infections resemble a common cold and improve in 1–2 weeks with home care:
However, seek prompt medical attention if you or your child experience:
You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to help decide whether to seek in-person care.
There is no specific antiviral treatment for most cases of RSV. Care focuses on relief of symptoms and supportive measures:
In severe cases—particularly for hospitalized infants or immunocompromised patients—treatments may include:
If you or your loved one develops severe symptoms—or if you’re unsure about the best next steps—always speak to a healthcare professional. For anything life-threatening or serious, seek immediate medical care.
(References)
* Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877. PMID: 19196675; PMCID: PMC4829966.
* Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev. 2017 Jan;30(1):277-319. doi: 10.1128/CMR.00010-16. PMID: 27903593; PMCID: PMC5217795.
* Russell CD, Unger SA, Walton M, Schwarze J. The Human Immune Response to Respiratory Syncytial Virus Infection. Clin Microbiol Rev. 2017 Apr;30(2):481-502. doi: 10.1128/CMR.00090-16. PMID: 28179378; PMCID: PMC5355638.
* Tseng HF, Sy LS, Ackerson B, Solano Z, Slezak J, Luo Y, Fischetti CA, Shinde V. Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection. J Infect Dis. 2020 Sep 14;222(8):1298-1310. doi: 10.1093/infdis/jiaa361. PMID: 32591787.
* Yao W, Pan J, Liu Z, Dong Z, Liang M, Xia S, Xiao Y, Cai X, Peng T, Zhou X, Cai H. The Cellular and Viral circRNAome Induced by Respiratory Syncytial Virus Infection. mBio. 2021 Dec 21;12(6):e0307521. doi: 10.1128/mBio.03075-21. Epub 2021 Dec 7. PMID: 34872355; PMCID: PMC8649777.
* Soni A, Kabra SK, Lodha R. Respiratory Syncytial Virus Infection: An Update. Indian J Pediatr. 2023 Dec;90(12):1245-1253. doi: 10.1007/s12098-023-04613-w. Epub 2023 Jun 16. PMID: 37326948.
* Yang Q, Xue B, Liu F, Lu Y, Tang J, Yan M, Wu Q, Chen R, Zhou A, Liu L, Liu J, Qu C, Wu Q, Fu M, Zhong J, Dong J, Chen S, Wang F, Zhou Y, Zheng J, Peng W, Shang J, Chen X. Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein. Signal Transduct Target Ther. 2024 Jun 10;9(1):144. doi: 10.1038/s41392-024-01858-5. Epub 2024 Jun 10. PMID: 38853183; PMCID: PMC11163014.
* de Sá JM, Thongpan I, Busso JS, Rodrigues TDS, Chen P, Helena AL, Regasini LO, Fossey MA, Caruso ÍP, de Souza FP, Peeples ME. Coumarins and Hesperetin Inhibit Human Respiratory Syncytial Virus Infection. Int J Mol Sci. 2024 Dec 11;25(24). doi: 10.3390/ijms252413301. Epub 2024 Dec 11. PMID: 39769063; PMCID: PMC11676883.
* Fearns R, Liang B. Introduction to Respiratory Syncytial Virus. Methods Mol Biol. 2025;2948:1-17. doi: 10.1007/978-1-0716-4666-3_1. PMID: 40879898.
* Adhikari S, Carrier C, Joshi PR, Baral P. β(2)-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection. Nat Commun. 2025 Dec 18;16(1):11229. doi: 10.1038/s41467-025-66401-8. Epub 2025 Dec 18. PMID: 41413286; PMCID: PMC12715253.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.